Atlas Trials

Rituximab in Interstitial Pneumonitis

Clinical trial NCT02251964 · COMPLETED

Trial details

NCT number
NCT02251964
Sponsor
Human Adams
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lung Diseases, InterstitialPneumonitis, Interstitial
Start date
2014-09-01
Primary completion
2017-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.